Latest Regulatory Approvals News

Transurban Group (ASX: TCL) declared a 35-cent unfranked distribution per stapled security for the six months ending 30 June 2026, payable in August with no approvals required.

HiTech Group Australia has tabled a conditional $15 million offer to acquire selected assets and employees from Hudson Global Resources, targeting the UpperGround business. The deal hinges on creditor approval, regulatory clearance, and financing, with payments structured across upfront, conditional, and deferred components.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.

ClearView Wealth has lodged its Scheme Booklet with ASIC, outlining Zurich's $0.65-per-share takeover offer and setting the stage for a pivotal shareholder vote on 27 July 2026.

Western Australia's State Government has backed VRX Silica's land swap proposal at Muchea, unlocking access to a significantly larger high-grade silica sand resource with lower environmental impact and paving the way for downstream glass manufacturing.

Elementos Limited has secured a key regulatory milestone as the Regional Government of Andalucía grants its Oropesa Tin Project Overriding Public Interest status, easing the path for critical water licensing and advancing permitting certainty.

Orpheus Uranium (ASX: ORP) is set to kick off its inaugural drilling program at the Erudina Uranium Prospect within the Frome Project, targeting a 10 km-long palaeochannel system with the aim of refining geological models and advancing towards a potential mineral resource.

Larvotto Resources has unveiled a substantial initial Exploration Target for the Midas Lode at its Hillgrove project, outlining a preferred 3.95 million tonnes at 5.16 g/t gold equivalent, accessible from surface and underground for near-term development.

Osteopore Limited has completed another incremental drawdown of A$250,000 on the second tranche of its redeemable convertible notes, continuing its steady funding progress under a A$20 million subscription agreement with Advance Opportunities Fund.

CleanSpace's AGILE respirator has achieved AS/NZS 17420.2:2021 certification, paving the way for commercialisation in Australia and New Zealand alongside its recent European approval.

Killi Resources has received regulatory approval to launch a major drilling campaign at its newly acquired Lodestone iron ore project, aiming to expand and upgrade a 110Mt inferred resource with a high-purity magnetite concentrate.